Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$897,021
+$9,216 QoQ
Shares Held
3,532
-2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#3,124
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Marks Group Wealth Management, Inc holds $11,856,271 across 9 Drug Manufacturers - General names. JNJ ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
54,996 | $2,882,890 | |
| 2 | AZN |
Astrazeneca PLC
|
14,483 | $2,746,265 | |
| 3 | AMGN |
Amgen Inc
|
6,591 | $2,386,732 | |
| 4 | LLY |
ELI LILLY & Co
|
1,445 | $1,733,176 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
3,532 | $897,021 | |
| 6 | ABBV |
AbbVie Inc.
|
1,501 | $377,710 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,546 | $327,161 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,201 | $278,073 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $897,021 | 3,532 | Shares | Other | 2026-07-28 | |
| 2026-03-31 | $887,805 | 3,632 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $772,336 | 3,732 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $728,699 | 3,930 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $600,307 | 3,930 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $731,685 | 4,412 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $638,063 | 4,412 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $926,010 | 5,714 | Shares | Other | 2024-10-30 | |
| 2024-06-30 | $834,281 | 5,708 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,040,256 | 6,576 | Shares | Other | 2024-04-29 | |
| 2023-12-31 | $1,052,509 | 6,715 | Shares | Other | 2024-02-01 | |
| 2023-09-30 | $1,005,988 | 6,459 | Shares | Other | 2023-10-30 | |
| 2023-06-30 | $3,538,982 | 21,381 | Shares | Other | 2023-07-19 | |
| 2023-03-31 | $3,264,610 | 21,062 | Shares | Other | 2023-05-03 | |
| 2022-12-31 | $3,349,283 | 18,960 | Shares | Other | 2023-02-06 | |
| 2022-09-30 | $2,870,888 | 17,574 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,842,644 | 16,014 | Shares | Other | 2022-08-09 | |
| 2022-03-31 | $2,425,214 | 13,684 | Shares | Other | 2022-05-10 | |
| 2021-12-31 | $1,952,592 | 11,414 | Shares | Sole | 2022-03-03 | |
| 2021-09-30 | $1,271,328 | 7,872 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,276,735 | 7,750 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,231,474 | 7,493 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,139,903 | 7,243 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,049,157 | 7,047 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $967,815 | 6,882 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $895,093 | 6,826 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||